Close Menu

cell-based assays

Cisbio Bioassays will use CellAura's flourescent reagents for non-radioactive assays for cellular studies.

StemCells said the restructuring will support the growth of the stem cell culture and cell-based assay platforms it inherited as part of its estimated $4.8 million acquisition of SCS in April.

Promega's luciferase reporters will be used in SABiosciences' assays.

The University of Lodz will use the system in its gene expression and screening projects.

The firms established a multi-year alliance, under which scientists from the companies will work together to develop hESC-based products for drug discovery.

Appearing in the online editions of Fungal Genetics and Biology and Microbiology, the papers describe the use of Biolog's Phenotype Microarray platform to research secondary pathways in F. graminearum, which is responsible for head blight and crop losses.

The firms are collaborating on providing drug-discovery support services with a focus on predictive toxicology.

Promega's ability to make hepatocytes is limited, so it made sense to partner with a company such as Celsis IVT that specializes in providing cells and other in vitro testing products, a Promega official said.

Pages

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.